These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28813711)

  • 1. Subjects at Risk for Genetic Late-Onset Neurological Diseases: Objective Knowledge.
    Leite Â; Leite F; Dinis MAP
    Public Health Genomics; 2017; 20(3):158-165. PubMed ID: 28813711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Illness representations, knowledge and motivation to perform presymptomatic testing for late-onset genetic diseases.
    Leite Â; Dinis MA; Sequeiros J; Paúl C
    Psychol Health Med; 2017 Feb; 22(2):244-249. PubMed ID: 26947204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological aspects of pre-symptomatic testing for Machado-Joseph disease and familial amyloid polyneuropathy type I.
    Rolim L; Leite A; Lêdo S; Paneque M; Sequeiros J; Fleming M
    Clin Genet; 2006 Apr; 69(4):297-305. PubMed ID: 16630162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjects At-Risk for Genetic Diseases in Portugal: Illness Representations.
    Leite Â; Dinis MA; Sequeiros J; Paúl C
    J Genet Couns; 2016 Feb; 25(1):79-89. PubMed ID: 25986962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mid- and long-term anxiety levels associated with presymptomatic testing of Huntington's disease, Machado-Joseph disease, and familial amyloid polyneuropathy.
    Lêdo S; Leite Â; Souto T; Dinis MA; Sequeiros J
    Braz J Psychiatry; 2016 Feb; 38(2):113-20. PubMed ID: 26870910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty Years of a Pre-Symptomatic Testing Protocol for Late-Onset Neurological Diseases in Portugal.
    Paneque M; Félix J; Mendes Á; Lemos C; Lêdo S; Silva J; Sequeiros J
    Acta Med Port; 2019 Apr; 32(4):295-304. PubMed ID: 31067424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-symptomatic testing for neurodegenerative disorders: Middle- to long-term psychopathological impact.
    Lêdo S; Leite Â; Souto T; Pimenta Dinis MA; Sequeiros J
    Psicothema; 2017 Nov; 29(4):446-452. PubMed ID: 29048302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Between responsibility and desire: Accounts of reproductive decisions from those at risk for or affected by late-onset neurological diseases.
    Mendes Á; Sequeiros J; Clarke AJ
    J Genet Couns; 2021 Oct; 30(5):1480-1490. PubMed ID: 33893685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease knowledge and attitudes toward predictive testing and prenatal diagnosis in families with Machado-Joseph disease from the Azores Islands (Portugal).
    Lima M; Kay T; Vasconcelos J; Mota-Vieira L; Gonzalez C; Peixoto A; Abade A; MacLeod P; Graca R; Santos J
    Community Genet; 2001; 4(1):36-42. PubMed ID: 11493751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and therapeutic implications of presymptomatic gene testing for familial amyloidotic polyneuropathy (FAP).
    Sales-Luís Mde L; Conceição I; de Carvalho M
    Amyloid; 2003 Aug; 10 Suppl 1():26-31. PubMed ID: 14640039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological well-being and family satisfaction levels five years after being confirmed as a carrier of the Machado-Joseph disease mutation.
    Gonzalez C; Gomes E; Kazachkova N; Bettencourt C; Raposo M; Kay TT; MacLeod P; Vasconcelos J; Lima M
    Genet Test Mol Biomarkers; 2012 Dec; 16(12):1363-8. PubMed ID: 23153003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
    Berg I; Thor S; Hammarström P
    Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term predictors for psychological outcome of pre-symptomatic testing for late-onset neurological diseases.
    Lêdo S; Ramires A; Leite Â; Dinis MAP; Sequeiros J
    Eur J Med Genet; 2018 Oct; 61(10):575-580. PubMed ID: 29581083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.
    Ebenezer GJ; Liu Y; Judge DP; Cunningham K; Truelove S; Carter ND; Sebastian B; Byrnes K; Polydefkis M
    Ann Neurol; 2017 Jul; 82(1):44-56. PubMed ID: 28598015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopathological dimensions in subjects with hereditary ATTR V30M amyloidosis and their relation with life events due to the disease.
    Lopes A; Fonseca I; Sousa A; Rodrigues C; Branco M; Coelho T; Sequeiros J; Freitas P
    Amyloid; 2018 Mar; 25(1):26-36. PubMed ID: 29357699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term psychological impact of predictive testing for Machado-Joseph disease: depression and anxiety levels in individuals at risk from the Azores (Portugal).
    Gonzalez C; Lima M; Kay T; Silva C; Santos C; Santos J
    Community Genet; 2004; 7(4):196-201. PubMed ID: 15692194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation.
    Okumura K; Yamashita T; Masuda T; Misumi Y; Ueda A; Ueda M; Obayashi K; Jono H; Yamashita S; Inomata Y; Ando Y
    Amyloid; 2016; 23(1):39-45. PubMed ID: 26763274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial impact of presymptomatic genetic testing for transthyretin amyloidotic polyneuropathy.
    Graceffa A; Russo M; Vita GL; Toscano A; Dattola R; Messina C; Vita G; Mazzeo A
    Neuromuscul Disord; 2009 Jan; 19(1):44-8. PubMed ID: 19084401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden.
    Soares ML; Coelho T; Sousa A; Holmgren G; Saraiva MJ; Kastner DL; Buxbaum JN
    Eur J Hum Genet; 2004 Mar; 12(3):225-37. PubMed ID: 14673473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?
    Bonaïti B; Olsson M; Hellman U; Suhr O; Bonaïti-Pellié C; Planté-Bordeneuve V
    Eur J Hum Genet; 2010 Aug; 18(8):948-52. PubMed ID: 20234390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.